Ancora Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Buy |
|
|||||
|
2025
Q1 | $123K | Sell |
|
|||||
|
2024
Q4 | $439K | Sell |
|
|||||
|
2024
Q3 | $652K | Sell |
|
|||||
|
2024
Q2 | $635K | Buy |
|
|||||
|
2024
Q1 | $662K | Buy |
|
|||||
|
2023
Q4 | $550K | Buy |
|
|||||
|
2023
Q3 | $482K | Buy |
|
|||||
|
2023
Q2 | $451K | Buy |
|
|||||
|
2023
Q1 | $415K | Buy |
|
|||||
|
2022
Q4 | $89K | Buy |
|
|||||
|
2022
Q3 | $57K | Sell |
|
|||||
|
2022
Q2 | $105K | Sell |
|
|||||
|
2022
Q1 | $161K | Hold |
|
|||||
|
2021
Q4 | $163K | Sell |
|
|||||
|
2021
Q3 | $160K | Sell |
|
|||||
|
2021
Q2 | $344K | Hold |
|
|||||
|
2021
Q1 | $307K | Sell |
|
|||||
|
2020
Q4 | $324K | Buy |
|
|||||
|
2020
Q3 | $276K | Hold |
|
|||||
|
2020
Q2 | $298K | Sell |
|
|||||
|
2020
Q1 | $315K | Sell |
|
|||||
|
2019
Q4 | $410K | Hold |
|
|||||
|
2019
Q3 | $373K | Sell |
|
|||||
|
2019
Q2 | $379K | Sell |
|
|||||
|
2019
Q1 | $449K | Sell |
|
|||||
|
2018
Q4 | $464K | Buy |
|
|||||
|
2018
Q3 | $475K | Sell |
|
|||||
|
2018
Q2 | $602K | Sell |
|
|||||
|
2018
Q1 | $670K | Buy |
|
|||||
|
2017
Q4 | $570K | Sell |
|
|||||
|
2017
Q3 | $770K | Buy |
|
|||||
|
2017
Q2 | $770K | Buy |
|
|||||
|
2017
Q1 | $699K | Sell |
|
|||||
|
2016
Q4 | $642K | Buy |
|
|||||
|
2016
Q3 | $443K | Buy |
|
|||||
|
2016
Q2 | $402K | Sell |
|
|||||
|
2016
Q1 | $378K | Buy |
|
|||||
|
2015
Q4 | $218K | Sell |
|
|||||
|
2015
Q3 | $211K | Buy |
|